V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211228 | 20078533 | 1.7 | 53.8 | Curative (C) | 2018-11-29 | 2018-12-27 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101035574 |
| 20211232 | 20078534 | 1.85 | 74.3 | Neo-adjuvant (N) | 2017-06-09 | 2017-06-14 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100223682 |
| 20211233 | 20078535 | 1.8 | 72 | Neo-adjuvant (N) | null | 2018-05-02 | CAPECITABINE + CARBOPLATIN | 2 | N | TRIAL UNSPECIFIED | 101722617 |
| 20211234 | 20078536 | 1.72 | 80 | Neo-adjuvant (N) | 2016-04-15 | 2016-04-25 | Capecitabine (21days) + Carboplatin | 02 | Y | TRIAL UNSPECIFIED | 100347584 |
| 20211236 | 20078537 | 1.62 | 84.4 | Palliative (P) | null | 2020-01-07 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100845703 |
| 20211237 | 20078538 | 1.73 | 73.6 | Palliative (P) | 2020-04-14 | 2020-04-24 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100922024 |
| 20211245 | 20078539 | 1.77 | 99.6 | Neo-adjuvant (N) | 2019-12-23 | 2019-12-29 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100678683 |
| 20211247 | 20078540 | 1.74 | 104 | Palliative (P) | 2018-04-01 | 2018-04-07 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100723756 |
| 20211249 | 20078541 | 1.74 | 51.7 | Palliative (P) | 2017-11-22 | 2017-11-22 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101161154 |
| 20211251 | 20078542 | 1.68 | 100 | Palliative (P) | 2018-01-16 | 2018-01-16 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101076501 |
| 20211253 | 20078543 | 0 | 0 | Neo-adjuvant (N) | 2019-07-10 | 2019-08-01 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100418478 |
| 20211262 | 20078544 | 1.66 | 70 | Curative (C) | 2019-05-09 | 2019-05-09 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101425409 |
| 20211264 | 20078545 | null | 83.3 | Neo-adjuvant (N) | 2018-12-01 | 2018-12-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100293766 |
| 20211275 | 20078546 | 0 | 0 | Palliative (P) | 2017-01-08 | 2017-01-28 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100791969 |
| 20211276 | 20078547 | 1.66 | 56 | Palliative (P) | 2019-01-06 | 2019-02-08 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100532364 |
| 20211277 | 20078548 | 0 | 0 | Neo-adjuvant (N) | 2019-07-08 | 2019-08-11 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101152605 |
| 20211283 | 20078549 | 1.85 | 64 | Palliative (P) | 2017-07-21 | 2017-07-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100988006 |
| 20211290 | 20078550 | 1.72 | null | null | 2018-04-10 | 2018-04-12 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101681432 |
| 20211292 | 20078551 | 1.64 | null | Palliative (P) | 2017-07-08 | 2017-07-08 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100159568 |
| 20211298 | 20078552 | 1.68 | 106 | Palliative (P) | 2018-01-02 | 2018-01-09 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101458371 |
| 20211303 | 20078553 | 1.69 | 87.4 | Curative (C) | 2018-03-18 | 2018-03-27 | Capecitabine (21days) + Carboplatin | 2 | Y | CAPECITABINE + CARBOPLATIN | 100915846 |
| 20211307 | 20078554 | 1.82 | 70 | Palliative (P) | 2018-04-24 | 2018-04-25 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100618681 |
| 20211309 | 20078555 | 1.67 | 50 | Neo-adjuvant (N) | 2016-03-14 | 2016-03-20 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100492441 |
| 20211312 | 20078556 | 1.62 | 66.25 | Palliative (P) | 2019-02-12 | 2019-02-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101569168 |
| 20211313 | 20078557 | 1.63 | 55.8 | null | 2016-10-14 | 2016-10-14 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100279552 |
| 20211316 | 20078558 | 1.75 | 65.6 | Palliative (P) | 2017-12-19 | 2017-12-28 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101162689 |
| 20211318 | 20078559 | 1.68 | 72 | Curative (C) | 2017-05-25 | 2017-05-31 | CISPLATIN + FLUOROURACIL | N | Y | CISPLATIN + FLUOROURACIL | 101499753 |
| 20211326 | 20078560 | 1.61 | 56.6 | Disease modification (D) | 2016-04-02 | 2016-04-02 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100831070 |
| 20211328 | 20078561 | 0 | 0 | Curative (C) | 2019-01-07 | 2019-01-07 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100932050 |
| 20211332 | 20078562 | 1.65 | 91.4 | null | 2019-07-20 | 2019-07-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101167832 |
| 20211333 | 20078563 | 1.66 | 58 | Palliative (P) | 2016-04-10 | 2016-04-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101221870 |
| 20211335 | 20078564 | 1.55 | 71.8 | Palliative (P) | 2018-03-19 | 2018-03-25 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101787074 |
| 20211337 | 20078565 | 1.71 | 83.3 | Palliative (P) | 2017-10-29 | 2017-11-08 | Capecitabine (21days) + Carboplatin | 2 | N | CAPECITABINE + CARBOPLATIN | 100127002 |
| 20211340 | 20078566 | 0 | 0 | Curative (C) | 2018-01-14 | 2018-01-15 | Doxorubicin chemoembolisation | null | Y | DOXORUBICIN EMBOLISATION | 101581624 |
| 20211341 | 20078567 | 0 | 0 | Palliative (P) | 2018-06-10 | 2018-06-10 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101485805 |
| 20211343 | 20078568 | 1.52 | 82 | Neo-adjuvant (N) | 2018-10-08 | 2018-10-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101228011 |
| 20211346 | 20078569 | 1.75 | 92.55 | Palliative (P) | 2016-07-11 | 2016-07-11 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100737897 |
| 20211350 | 20078570 | 1.53 | 92.55 | Neo-adjuvant (N) | 2017-10-22 | 2017-10-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100832377 |
| 20211353 | 20078571 | 1.7 | 94.3 | Palliative (P) | 2017-08-19 | 2017-08-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101545213 |
| 20211354 | 20078572 | 1.68 | 92 | Palliative (P) | 2018-12-30 | 2019-01-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100579519 |
| 20211356 | 20078573 | 1.53 | 113.6 | Palliative (P) | 2016-08-11 | 2016-08-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101714604 |
| 20211362 | 20078575 | 1.77 | 135 | null | 2018-09-25 | 2018-10-08 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100788513 |
| 20211363 | 20078576 | 1.66 | 71.6 | null | 2017-09-03 | 2017-09-03 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101028035 |
| 20211366 | 20078577 | 1.74 | 73 | Neo-adjuvant (N) | 2017-07-27 | 2017-09-05 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101117797 |
| 20211371 | 20078578 | 1.71 | 65 | Curative (C) | 2017-11-06 | 2017-11-09 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100410631 |
| 20211378 | 20078579 | 1.64 | 103.4 | null | 2019-04-24 | 2019-05-01 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100994968 |
| 20211380 | 20078580 | 1.5 | 90.6 | 03 | 2019-01-09 | 2019-01-16 | CAPECITABINE + CARBOPLATIN | N | N | CISPLATIN + FLUOROURACIL | 100113657 |
| 20211382 | 20078581 | 1.75 | 85.6 | null | 2019-01-19 | 2019-02-03 | Capecitabine + Carboplatin + RT | 02 | null | CAPECITABINE + CARBOPLATIN | 101432615 |
| 20211388 | 20078582 | 1.94 | 43 | null | 2019-05-25 | 2019-06-21 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101124640 |
| 20211389 | 20078583 | 1.7 | 85.4 | Palliative (P) | 2020-01-21 | 2020-01-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100231399 |